MindPath Care Centers Hosts Open House in Charlotte to Introduce FDA-Cleared Deep TMS™ Treatment for Major Depressive Disor...
July 13 2021 - 11:00AM
MindPath Care Centers, a Community Psychiatry practice dedicated to
providing mental and behavioral healthcare, announced today that it
will host an open house on July 15. The event will feature an
opportunity for local mental health providers in the Charlotte area
to meet the MindPath Care Center staff and watch live
demonstrations of BrainsWay’s Deep Transcranial Magnetic
Stimulation (Deep TMS™) treatment offerings for major depressive
disorder (MDD) and obsessive-compulsive disorder (OCD). Eligibility
for Deep TMS varies by patient and insurance details. For more
information on patient eligibility, visit BrainsWay.com.
Details on the open house are as follows:
Date: Thursday, July 15Time: 6:00 p.m. - 7:30 p.m.Address: 6060
Piedmont Row Drive South, Suite 500, Charlotte, N.C. 28287
Those interested in attending should RSVP to
outreach@mindpathcare.com by Wednesday
morning. Attendance is limited.
“Deep TMS is a potent combination of state-of-the-art brain
science and technology,” said Sandeep Vaishnavi, M.D., P.H.D.,
Medical Director of MindPath Care Centers’ Interventional
Psychiatry and Clinical Research Institute. “By offering Deep TMS
for treatment-resistant major depressive disorder and OCD, we’ve
expanded our services to reach a wider range of patients in the
area who may have lost hope without knowing of an alternative
treatment.”
BrainsWay’s Deep TMS device noninvasively
administers magnetic waves through a cushioned helmet to target
deep structures of the brain that impact depression, OCD, and
smoking addiction symptoms. The treatment offers a medication-free
solution, and patients can return to normal activities, such as
driving, immediately following the 20-minute sessions. Because Deep
TMS penetrates deeper and broader in the brain than traditional
TMS, there is evidence that response rates are higher than
traditional TMS. BrainsWay has treated over 100,000 patients with
Deep TMS since the treatment received FDA clearance for depression
in 2013, OCD since 2018, and most recently smoking addiction in
2020.
"Although individual results vary, the vast majority of our Deep
TMS patients at MindPath Care Centers experience a level of
improvement that allows them to enjoy life again, to work,
socialize, and reconnect with hobbies and interests. It really is
quite remarkable!” said Caroll Brammer, MBA, Director of
Interventional Psychiatry.
MindPath Care Centers’ Charlotte location is committed to
providing high-quality, compassionate, comprehensive mind care to
help individuals and loved ones live a life as healthy and happy as
possible. The psychiatry practice offers mental health treatment
services including Deep TMS treatment for depression and OCD,
medication management, and individual therapy both in office and
via telehealth. For more information regarding Deep TMS services at
MindPath Care Centers, visit www.mindpathcare.com/TMS or call the
clinic at 877-876-3783.
About MindPath Care CentersCommunity Psychiatry
and MindPath Care Centers have combined to expand patient access to
high-quality, evidence-based, outpatient mental health care across
the United States. Our more than 350 psychiatrists, psychiatric
nurse practitioners, psychologists and licensed therapists deliver
care through telehealth and in-person visits at 70+ locations in
five states in partnership with most major health insurance
providers. Together, Community Psychiatry and MindPath Care Centers
share a focus on providing comprehensive, integrated care and
individualized mental health treatment services, including
medication management and individual therapy both in office and via
telehealth, TMS (transcranial magnetic stimulation) therapy and
addiction recovery services. Our collaborative care approach and
integration of the latest mental health treatments and technologies
ensure our patients receive the continuum of care required for
optimal outcomes. For more information, please visit
communitypsychiatry.com and mindpathcare.com.
About BrainsWayBrainsWay is a
global leader in advanced noninvasive neurostimulation treatments
for mental health disorders. The Company is boldly advancing
neuroscience with its proprietary Deep Transcranial Magnetic
Stimulation (Deep TMS) platform technology to improve health and
transform lives. BrainsWay is the first and only TMS company to
obtain three FDA-cleared indications backed by pivotal studies
demonstrating clinically proven efficacy. Current indications
include major depressive disorder, obsessive-compulsive disorder,
and smoking addiction. The Company is dedicated to leading through
superior science and building on its unparalleled body of clinical
evidence. Additional clinical trials of Deep TMS in various
psychiatric, neurological, and addiction disorders are underway.
Founded in 2003, with offices in Cresskill, NJ and Jerusalem,
Israel, BrainsWay is committed to increasing global awareness and
broad access to Deep TMS. For the latest news and information about
BrainsWay, please visit www.brainsway.com.
MindPath Care Centers Media Contact:Mindy M.
Hallcpsych@wearemgp.com(415) 889-9977
BrainsWay Media Contact:Will
JohnsonBrainsway@antennagroup.com (201) 465-8019
Brainsway (NASDAQ:BWAY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Brainsway (NASDAQ:BWAY)
Historical Stock Chart
From Apr 2023 to Apr 2024